These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 16081646)

  • 1. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
    Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
    Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
    Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
    J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I; Keller H; Leupin O; Kneissel M
    Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
    Bellido T
    J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
    Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
    J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
    Li C; Wang W; Xie L; Luo X; Cao X; Wan M
    Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological function of bone cells on the PTH-driven anabolic effect].
    Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
    Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent PTH treatment can delay the transformation of mature osteoblasts into lining cells on the periosteal surfaces.
    Jang MG; Lee JY; Yang JY; Park H; Kim JH; Kim JE; Shin CS; Kim SY; Kim SW
    J Bone Miner Metab; 2016 Sep; 34(5):532-9. PubMed ID: 26303221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.
    Gooi JH; Pompolo S; Karsdal MA; Kulkarni NH; Kalajzic I; McAhren SH; Han B; Onyia JE; Ho PW; Gillespie MT; Walsh NC; Chia LY; Quinn JM; Martin TJ; Sims NA
    Bone; 2010 Jun; 46(6):1486-97. PubMed ID: 20188226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D
    Wijenayaka AR; Prideaux M; Yang D; Morris HA; Findlay DM; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2016 Nov; 164():369-373. PubMed ID: 26690786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
    Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
    J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
    Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
    Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
    Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
    Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
    Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
    Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
    Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
    J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.
    Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y
    Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.